Summit Therapeutics
SMMT
SMMT
14 hedge funds and large institutions have $6.54M invested in Summit Therapeutics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $51K
Holders
14
Holding in Top 10
–
Calls
–
Puts
$51K
Top Buyers
| 1 | +$153K | |
| 2 | +$43.8K | |
| 3 | +$36.1K | |
| 4 |
JP Morgan Chase
New York
|
+$34.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.05K |
Top Sellers
| 1 | -$604K | |
| 2 | -$478K | |
| 3 | -$164K | |
| 4 |
Millennium Management
New York
|
-$126K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$57K |